<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000410212">
  <TermName>pioglitazone</TermName>
  <TermPronunciation>(py-oh-GLIH-tuh-zone)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug that is used to treat type 2 diabetes and is being studied in the prevention of head and neck cancer. It may be able to stop leukoplakia (a condition affecting the mouth ) from developing into cancer. It is a type of thiazolidinedione. Also called Actos.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000713092" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pioglitazone&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000713091" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pioglitazona&quot;" language="es" id="_4"/>
  <SpanishTermName>pioglitazona</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para tratar la diabetes tipo 2 y que está en estudio para prevenir el cáncer de cabeza y  cuello.; podría impedir que la leucoplaquia (afección que afecta la boca) se convierta en cáncer. Es un tipo de tiazolidinediona. También se llama Actos.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2005-05-23</DateFirstPublished>
  <DateLastModified>2009-06-18</DateLastModified>
</GlossaryTerm>
